Lung Involvement in Extra Respiratory Diseases: The Importance of a Multidisciplinary Approach

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 1733

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical Sciences-Pulmonology, University of Medicine and Pharmacy, "Iuliu Hatieganu", 400012 Cluj Napoca, Romania
Interests: interstitial lung disease; idiopathic pulmonary fibrosis; severe asthma; rare lung diseases

E-Mail Website
Guest Editor
Department of Medical Sciences-Pulmonology, University of Medicine and Pharmacy, "Iuliu Hatieganu", 400012 Cluj Napoca, Romania
Interests: respiratory disorders during sleep; noninvasive ventilation; interstitial lung disease secondary autoimmune diseases

E-Mail Website
Guest Editor
1. Department of Pulmonology II, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
2. Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania
Interests: smoke free environments; obstructive respiratory diseases; sleep apnea; noninvasive ventilation; bronchiectasis; adherence issues; interstitial lung diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The present issue aims to give an overview of new challenges in diagnosing and managing various clinical entities that have an impact on the lungs and to emphasize the importance of a multidisciplinary approach. This ranges from analyzing the effect of drugs on the respiratory tract (interstitial lung involvement secondary to oncologic therapy, immunosuppressive therapy, or cardiac therapy) to evaluating lung involvement in inflammatory bowel disease, neurological disease (brain–lung interaction), heart disease (the eternal dilemma: is it a cardiology or respiratory patient?), eye disease, infectious disease, endocrinological or skin disease. This issue intends to cover lung conditions in particular situations such as pregnancy (drugs in pregnancy and their impact on pulmonary involvement, sleep apnea in pregnant women), surgical patients (before and after the surgery), and patients with mental illnesses (underdiagnosed or misdiagnosed mental illnesses in chronic respiratory diseases and risk factors for respiratory disorders in chronic psychiatric patients).

We look forward to your collaboration.

Best regards,

Dr. Milena Adina Man
Dr. Nicoleta Stefania Motoc
Prof. Dr. Florin Mihaltan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lung diseases
  • lung involvement in extra respiratory conditions
  • extra respiratory manifestations
  • interstitial lung diseases
  • drug-induced lung diseases
  • lung diseases in pregnancy
  • lung involvement in inflammatory bowel disease
 
 

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 2938 KiB  
Review
A Multidisciplinary Approach as a Goal for the Management of Complications in Systemic Scleroderma: A Literature Review and Case Scenario
by Dariana-Elena Pătrîntașu, Hédi Katalin Sárközi, Eugeniu Lupușor, Irina Elena Vlangăr, Gheorghe-Marian Rotariu, Ionuț-Alexandru Rența, Anda-Nicoleta Nan and Corina Eugenia Budin
Diagnostics 2023, 13(21), 3332; https://doi.org/10.3390/diagnostics13213332 - 28 Oct 2023
Viewed by 1107
Abstract
Systemic sclerosis (also known as scleroderma) is a chronic fibrosing autoimmune disease with both skin and multisystem organ involvement. Scleroderma has the highest mortality among all rheumatic diseases. The pathophysiology mechanism of systemic sclerosis is a progressive self-amplifying process, which involves widespread microvascular [...] Read more.
Systemic sclerosis (also known as scleroderma) is a chronic fibrosing autoimmune disease with both skin and multisystem organ involvement. Scleroderma has the highest mortality among all rheumatic diseases. The pathophysiology mechanism of systemic sclerosis is a progressive self-amplifying process, which involves widespread microvascular damage, followed by a dysregulation of innate and adaptive immunity and inflammation and diffuse fibrosis of the skin and visceral organs. Fibrosis of internal organs is a hint for systemic sclerosis, moreover associated with interstitial lung disease (SSc-ILD) is a complex process. In order to correlate scientific data from the literature with clinical experience, we present the case of a 56-year-old woman who was diagnosed with systemic sclerosis 16 years ago. The association of numerous comorbidities characterized by a considerable level of seriousness characterizes this case: the highly extensive systemic damage, the cardiovascular impact of the illness, and the existence of severe pulmonary arterial hypertension. The systemic and clinical manifestations, respiratory functional tests, radiological features, and specific therapy are discussed. Full article
Show Figures

Figure 1

Back to TopTop